DOXGX | GEICX | DOXGX / GEICX | |
Total Expense Ratio | 0.41 | 2.18 | 19% |
Annual Report Gross Expense Ratio | 0.46 | 2.18 | 21% |
Fund Existence | 3 years | 2 years | - |
Gain YTD | 9.064 | 12.149 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116B | 463M | 25,054% |
Annual Yield % from dividends | 1.43 | 12.94 | 11% |
Returns for 1 year | 5.29 | -1.07 | -492% |
Returns for 3 years | 34.21 | N/A | - |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 23.00 | 0.43 | +1.91% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
HELX | 30.62 | 0.36 | +1.20% |
Franklin Genomic Advancements ETF | |||
FNDC | 44.16 | 0.39 | +0.89% |
Schwab Fundamental International SmEqETF | |||
KBWD | 14.38 | 0.02 | +0.14% |
Invesco KBW High Dividend Yld Fincl ETF | |||
WDTE | 33.43 | -0.06 | -0.17% |
Defiance S&P 500 Target 30 Income ETF |